Application
of Farnesol for reversing drug resistance of Mycobacterium via inhibiting
activity of secreted protein has been reported in a Chinese patent
[CN102125536]. The invention provides
four isomeric structural formulas of Farnesol [2,6,10-dodecatrien-1-ol,
3,7,11-trimethyl]
[2E,6E]
– [106-28-5]
[2Z,6E]
– [3790-71-4]
[2E,6Z]
– [3879-60-5]
[2Z,6Z]
– [16106-95-9]
Key Words: multidrug resistant tuberculosis, extensively drug resistant tuberculosis, multidrug resistant TB, extensively drug resistant TB, MDR TB, XDR TB, mycobacterium tuberculosis, mycobacterial infection, literature, research, publications, patents.
Key Words: multidrug resistant tuberculosis, extensively drug resistant tuberculosis, multidrug resistant TB, extensively drug resistant TB, MDR TB, XDR TB, mycobacterium tuberculosis, mycobacterial infection, literature, research, publications, patents.
No comments:
Post a Comment